Skip to main content
SpringerLink
Log in

IFN-α-Konsolidierung nach intensiver Chemotherapie bringt keinen Überlebensvorteil bei niedrigmalignen Non-Hodgkin-Lymphomen

  • Literatur Kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Aviles A, Duque G, et al. Interferon alpha 2b as maintenance therapy in Low grade malignant lymphoma improves duration of remission and survival. Leuk Lymphoma 1996;20:495–9.

    Article  CAS  PubMed  Google Scholar 

  2. Fisher RI, Dana BW, Michael LeBtanc M, et al. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with Low-grade non-Hodgkin's lym phoma: Results of the Southwest Oncology Group randomized phase III study 8809. J CLin Oncol 2000:18:2010–6.

    CAS  PubMed  Google Scholar 

  3. Peterson BA, Petroni G. Oken MM. et al. Cyclophosphamide versus cyclophosphamide plus interferon atfa-2b in follicular low grade Lymphomas. A preliminary report of an intergroup trial (CALGB 8691 and EST 7486). Proc Am Soc Clin Oncol 1993:12:366.abstract 1240.

  4. Rohatiner AZS, Crowther D, Radfort JOA, et al. The role of interferon on follicular lymphoma. Proc Am Soc CLin Oncol 1996;15:418-abstract 12B5.

  5. Smalley RV, Andersen JW, Hawkins MJ, et al. Interferon alpha combined with cytotoxic chemotherapy far patients with non-Hodgkin's lymphoma. N Engl J Med 1992;327:1336–41.

    Article  CAS  PubMed  Google Scholar 

  6. Solar-Celigny P, Lepage E, Brousse N, et al. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. N Engl J Med 1993;329:1608–14.

    Article  Google Scholar 

  7. Solal-Celigny P, Lepage E, Brousse N. et al. Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular Lymphomas: Final analysis of survival and toxicity in the Groupe d'Etude des Lymphomas Folliculaires 86 Trial. J Clin Oncol 1998;16:2332–8.

    CAS  PubMed  Google Scholar 

  8. Unterhalt M, Herrmann R, Nahler M, et al. Significant prolongation of disease free survival in advanced low grade non Hodgkin lymphomas by interferon alpha maintenance. Blood 1995;86:439.abstract 1744.

Download references

Author information

Authors and Affiliations

  1. Oldenburg

    M. Klee & H.J. Illiger

Authors
  1. M. Klee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H.J. Illiger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klee, M., Illiger, H. IFN-α-Konsolidierung nach intensiver Chemotherapie bringt keinen Überlebensvorteil bei niedrigmalignen Non-Hodgkin-Lymphomen. Strahlenther Onkol 177, 494–495 (2001). https://doi.org/10.1007/BF03353387

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03353387

Search

Navigation